President Trump Invokes

President Trump Invokes Defense Production Act to Fight COVID-19

President Donald Trump speaks during press briefing with the Coronavirus Task Force, at the White House, Wednesday, March 18, 2020, in Washington. (AP Photo/Evan Vucci)

OAN Newsroom
UPDATED 1:12 PM PT — Wednesday, March 18, 2020

President Trump has invoked the Defense Production Act to combat the coronavirus. He made the announcement alongside the coronavirus task force during Wednesday’s press briefing.

The move will allow the White House to order increased production and distribution of medical supplies like masks, ventilators and respirators. It will also expand hospital capacity to combat the pandemic.

The president also announced the Level 1 activation of FEMA in all 50 states and described himself as a “wartime president.”

“Now it is our time. We must sacrifice together, because we are all in this together. We’ll come through together. It’s always the toughest enemy, the invisible enemy, but we’re going to defeat the invisible enemy. I think we’re going to do it even faster than we thought, and it will be a complete victory.”

– Donald Trump, 45th President of the United States

He is planning to meet with nurses on the front lines and will host a conference call with the nation’s governors on Thursday to discuss nationwide access to FEMA moving forward. According to the president, vaccine development is moving along faster than any in history.

“Thanks to the unprecedented partnership between the FDA, NIH and the private sector, we’ve reached human trials for the vaccine just eight weeks later,” he said. “That’s a record by many, many months,…that’s the fastest development in history.”

Pharmacist Michael Witte opens a package taken from a freezer that contains the potential vaccine for COVID-19, the disease caused by the new coronavirus, on the first day of a first-stage safety study clinical trial of the vaccine, Monday, March 16, 2020, at the Kaiser Permanente Washington Health Research Institute in Seattle. (AP Photo/Ted S. Warren)

A Southern California laboratory has been working around the clock on a potential vaccine. San Diego-based biotech company Arcturus Therapeutics has reportedly been developing a vaccine, which requires a low-dose, single injection of antigen.

According to the CEO, antigen inside a patient’s body continues to develop for a few weeks, eventually creating an immune response.

“Those little tiny spikes that you see on the coronavirus, that’s what we want to build inside the body. In order to do that, we inject RNA. Once it gets inside the cell, it makes and creates the antigen…those little spikes. Once the body sees the spikes, it builds up an immune response and protects us from the real thing, the coronavirus.”

– Joe Payne, CEO of Arcturus Therapeutics

The vaccine would be manufactured in the U.S. and clinical trials would take place in Singapore.

MORE NEWS: President Trump Says Financial Help Is On The Way To Those Affected By Public Health Crisis

Spread the love